ALKS

NASD Alkermes Public Limited Company
Oct 3, 2026 · 3:27 AM ET EOD Market Closed

$41.75 ↑ +0.00 (+0.00%) Trading Up from the previous close of $41.75, $0.21 below the day’s high of $41.96

YTD change
+49.21%
vs 20-day SMA
-4.81%
vs 200-day SMA
+6.99%

Price ranges

Previous day
$40.32 $41.96
open $41.03 close $41.75
+$0.72 (+1.75%)
Today
$40.32 $41.96
$41.75
Past week
$39.84 $41.41
from $40.79 now $41.75
+$0.96 (+2.35%)
Past month
$39.84 $48.29
from $47.72 now $41.75
-$5.97 (-12.51%)
This year
$27.00 $55.67
from $27.98 now $41.75
+$13.77 (+49.21%)

Price & Performance

+7.67 (+22.51%) / 6M

$31.24$39.83$48.41$57.00Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 41.4% away from all-time highs of $71.22
  • ALKS is up 49% since the beginning of the year
  • ALKS is up 34% over the past 12 months
  • ALKS is down 13% over the past 1 month
  • 9% of all ALKS investors are betting against ALKS

ALKS reads neutral: price sits above one of the two key moving averages, the 12-month move is +34.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum +100.0% Quarterly EPS growth
Quarterly change +100.0%

Valuation

P/E ratio 45.02
Enterprise value $7.9B
Beta 0.59

Balance sheet & scale

Income$66.1K
Revenue$1.7B
Cash$656.6M
Debt$1.6M
Income / Debt 0.04×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $7.0B

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.